Nakamura, T., Miyamoto, T., Tanada, D., Nishii, R., Okamura, S., Inui, T., Doi, Y., Tanaka, K., Yanai, M., Hirose, M., & Kimura, T. (2024). Initial dose of tapentadol and concomitant use of duloxetine are associated with delirium occurring after initiation of tapentadol therapy in cancer patients. Journal of Opioid Management, 20(6), 495–502. https://doi.org/10.5055/jom.0859